Alx Oncology Holdings Inc (NASDAQ: ALXO) kicked off on Monday, up 6.17% from the previous trading day, before settling in for the closing price of $1.62. Over the past 52 weeks, ALXO has traded in a range of $1.19-$17.83.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -8.67% over the past five years. While this was happening, its average annual earnings per share was recorded 26.31%. With a float of $34.30 million, this company’s outstanding shares have now reached $52.74 million.
Let’s look at the performance matrix of the company that is accounted for 72 employees. In terms of profitability, gross margin is 74.15%, operating margin of -6446.65%, and the pretax margin is -6095.12%.
Alx Oncology Holdings Inc (ALXO) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Alx Oncology Holdings Inc is 34.96%, while institutional ownership is 58.48%. The most recent insider transaction that took place on Dec 02 ’24, was worth 46,404. In this transaction Director of this company bought 30,000 shares at a rate of $1.55, taking the stock ownership to the 33,000 shares. Before that another transaction happened on Aug 14 ’24, when Company’s SVP, FINANCE AND CAO sold 564 for $2.58, making the entire transaction worth $1,455. This insider now owns 91,549 shares in total.
Alx Oncology Holdings Inc (ALXO) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 26.31% per share during the next fiscal year.
Alx Oncology Holdings Inc (NASDAQ: ALXO) Trading Performance Indicators
Take a look at Alx Oncology Holdings Inc’s (ALXO) current performance indicators. Last quarter, stock had a quick ratio of 4.82.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.98, a number that is poised to hit -0.67 in the next quarter and is forecasted to reach -2.50 in one year’s time.
Technical Analysis of Alx Oncology Holdings Inc (ALXO)
Alx Oncology Holdings Inc (NASDAQ: ALXO) saw its 5-day average volume 1.27 million, a positive change from its year-to-date volume of 0.79 million. As of the previous 9 days, the stock’s Stochastic %D was 65.81%. Additionally, its Average True Range was 0.15.
During the past 100 days, Alx Oncology Holdings Inc’s (ALXO) raw stochastic average was set at 9.39%, which indicates a significant decrease from 77.94% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 104.76% in the past 14 days, which was lower than the 116.26% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5125, while its 200-day Moving Average is $7.0163. Nevertheless, the first resistance level for the watch stands at $1.7933 in the near term. At $1.8667, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.9433. If the price goes on to break the first support level at $1.6433, it is likely to go to the next support level at $1.5667. Assuming the price breaks the second support level, the third support level stands at $1.4933.
Alx Oncology Holdings Inc (NASDAQ: ALXO) Key Stats
The company with the Market Capitalisation of 81.19 million has total of 52,743K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -160,810 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -30,710 K.
